Cannabis Products and the Potential Impact on Patients

In this FDA Drug Topics Webinar, guests: Cassandra Taylor, PhD, Scott Janiczak, PharmD, MPH, BCPS, and Stephen Galati, MD, identify cannabis products on the market and how they differ from FDA regulated human drugs, as well as the various ways that those products are manufactured and how the quality controls are different. They will also explain the potential risks that are associated with cannabis use. In addition they will briefly review of some of the scientific evidence. They will talk about approaches for initiating discussions with the patient interactions.
And lastly, they will discuss how to submit a voluntary adverse event report or a consumer complaint to the FDA.
Questions? Email [e-mail]